Viktor Yarotskyy

Summary

Affiliation: University of Rochester
Country: USA

Publications

  1. ncbi Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation
    Viktor Yarotskyy
    Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Pharmacol Exp Ther 340:463-72. 2012

Collaborators

Detail Information

Publications1

  1. ncbi Roscovitine inhibits CaV3.1 (T-type) channels by preferentially affecting closed-state inactivation
    Viktor Yarotskyy
    Department of Pharmacology and Physiology, University of Rochester Medical Center, 601 Elmwood Avenue, Rochester, NY 14642, USA
    J Pharmacol Exp Ther 340:463-72. 2012
    ..The ability of roscovitine to block multiple mediators of proliferation, including CDKs and Ca(V)3.1 channels, may facilitate its anticancer properties...